南非的一项试验显示,中风药物DM199可以治疗先兆子痫,减少母婴的风险。 A South African trial shows DM199, a stroke drug, may treat preeclampsia, reducing risks for mothers and babies.

南非一项临床试验显示，一种新药DM199在治疗妊娠前期（一种危及生命的妊娠疾病）方面取得了有希望的效果，该药物最初是为中风开发的。 A clinical trial in South Africa has shown promising results for a new drug, DM199, originally developed for stroke, in treating preeclampsia, a life-threatening pregnancy condition. Abigail Hendricks是来自开普敦的33岁妇女,在第五次怀孕期间经历了严重的先兆子痫,血压和器官损伤非常高。 Abigail Hendricks, a 33-year-old woman from Cape Town, experienced severe preeclampsia during her fifth pregnancy, with dangerously high blood pressure and organ damage. 在最初剂量199德国马克后,没有任何效果,高剂量导致第16名患者明显改善,包括降低血压和改善血管健康。 After initial doses of DM199 showed no effect, a higher dose led to significant improvement in the 16th patient, including reduced blood pressure and better vascular health. 该药物目前正在进一步研究,可能有助于推迟早产和保护母亲和婴儿。 The drug, now under further study, may help delay premature delivery and protect both mother and baby. 全世界每年至少造成42 000名孕产妇死亡的先兆子痫。 Preeclampsia causes at least 42,000 maternal deaths annually worldwide.